Mar. 14 at 12:46 PM
$CFRXQ In case any of you care: bankruptcy court is close to approving the sale of CFRX's IP and equipment to a company in France called Aurobac therapeutics. It was all initially valued at
$200K but the final bid was for
$820K. Roggie (CFRX's disgraced CEO) made a bid but lost out.
Perhaps if you really believe CFRX's lysins still have a chance after two failed clinical trials this company would be the one to follow. As far as any recourse for your lost money I wouldn't count on it at this point. CFRX listed "assets of
$609.53 million and liabilities of
$9.32 million" in the Chapter 7 and selling their equipment and IP for less than 2% of that valuation does not bode well.